Contrarius Investment Management Ltd - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 83 filers reported holding ARALEZ PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
Contrarius Investment Management Ltd ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$495,000
+69.5%
216,2110.0%0.03%
+45.0%
Q2 2017$292,000
-36.9%
216,2110.0%0.02%
-33.3%
Q1 2017$463,000
-55.4%
216,211
-8.1%
0.03%
-61.5%
Q4 2016$1,037,000
-16.8%
235,174
-8.5%
0.08%
-15.2%
Q3 2016$1,247,000
+26.6%
257,131
-13.9%
0.09%
+9.5%
Q2 2016$985,000
-32.3%
298,555
-27.1%
0.08%
-34.9%
Q1 2016$1,455,000409,7560.13%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Rubric Capital Management, LLC 237,547$843,00013.09%
JW Asset Management, LLC 1,836,375$6,519,0004.26%
DRILL CRAIG A 339,300$1,205,0003.04%
Tiger Legatus Capital Management, LLC 1,275,000$4,526,0001.80%
Broadfin Capital, LLC 3,800,000$13,490,0001.30%
Healthcare Value Capital, LLC 175,000$621,0000.91%
Kavi Asset Management, LP 313,627$1,113,0000.87%
Healthcare Value Capital, LLC 100,000$355,0000.52%
Elk Creek Partners, LLC 1,392,746$4,944,0000.37%
Par Capital Management 5,365,000$19,046,0000.30%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders